on RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
BioVie and FibroBiologics Feature on RedChip Show on Bloomberg TV
RedChip Companies announced that it will broadcast interviews with BioVie Inc. and FibroBiologics, Inc. on its show, "Small Stocks, Big Money™," airing on Bloomberg TV on September 27. The program, reaching approximately 73 million U.S. homes, will feature insights from both companies' CEOs.
Cuong Do, President and CEO of BioVie, will discuss the potential of bezisterim (NE3107), targeting Alzheimer's, Parkinson's, and Long COVID. He will also detail BIV201, designed for refractory ascites in liver cirrhosis. BioVie's programs are advancing with strong clinical data and market potential.
Pete O'Heeron, CEO of FibroBiologics, highlights the company's fibroblast-based therapies in their robust pipeline, including CYWC628 for diabetic foot ulcers. They aim for large markets with over 240 patents supporting their scalable platform.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all RedChip Companies, Inc. (Media Suite) news